Related Experiment Video
Updated: Dec 24, 2025
05:30
Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration
Published on: May 19, 2023
1.7K
Correction: Heparin-stabilised iron oxide for MR applications: a relaxometric study
Lucy Ternent1, Daniel Alexander Mayoh, Martin Richard Lees
1Molecular Organisation and Assembly in Cells Doctoral Training Centre, Coventry House, University of Warwick, Coventry CV4 7AL, UK.
Journal of Materials Chemistry. B
|April 9, 2020
Summary
This correction clarifies details regarding heparin-stabilised iron oxide nanoparticles for magnetic resonance imaging (MRI) applications. The study focuses on their relaxometric properties, crucial for enhancing MRI contrast agents.
Area of Science:
- Materials Science
- Biomedical Engineering
- Nanotechnology
Background:
- Iron oxide nanoparticles are investigated for magnetic resonance imaging (MRI) contrast enhancement.
- Heparin stabilization is explored to improve nanoparticle properties for biomedical applications.
Purpose of the Study:
- To correct and clarify specific details within the original publication.
- To ensure accurate reporting of the relaxometric properties of heparin-stabilised iron oxide nanoparticles.
Main Methods:
- Relaxometry measurements were conducted on heparin-stabilised iron oxide nanoparticles.
- Data analysis focused on relaxation times (longitudinal and transverse) to determine relaxivity.
Main Results:
- The correction addresses specific numerical values and interpretations related to relaxivity.
- Ensures accurate characterization of the magnetic properties for MRI applications.
Conclusions:
- Accurate relaxometric data is essential for the development of effective MRI contrast agents.
- Clarifications support the reliable application of these nanoparticles in medical imaging.
